S&P 500
773.26
+0.61%
DOW
539.62
+0.27%
NASDAQ
723.03
+1.17%
Russell
301.56
+1.11%
VIX
21.62
+0.28%
FTSE
48.64
+0.70%
Nikkei
96.90
+1.84%
BTC
64,972.02
+0.82%
ETH
1,914.93
+0.43%
Gold
398.47
+2.26%
Oil
117.98
-0.75%
Silver
57.50
+2.95%
S&P 500
773.26
+0.61%
DOW
539.62
+0.27%
NASDAQ
723.03
+1.17%
Russell
301.56
+1.11%
VIX
21.62
+0.28%
FTSE
48.64
+0.70%
Nikkei
96.90
+1.84%
BTC
64,972.02
+0.82%
ETH
1,914.93
+0.43%
Gold
398.47
+2.26%
Oil
117.98
-0.75%
Silver
57.50
+2.95%
Stock
Ti
News
Markets
Stocks
Screener
Calendar
Watchlist
Loading...
Home
/
Stocks
/
JAZZ
/
News
JAZZ
NASDAQ · Pharmaceuticals
Jazz Pharmaceuticals Plc
Large-Cap Stocks
Blue Chip Stocks
Pharmaceutical Stocks
Healthcare Stocks
$256.56
-0.09 (-0.04%)
☆ Watch
As of Aug 9, 9:45 PM ET ·
Overview
Earnings
Forecast
Financials
News
Peers
Technicals
JAZZ News
1 articles
AbCellera Shares Jump 9.7% Ahead of Key Phase 2 Data Release
AbCellera (ABCL) rose 9.7% after hours as investors await Phase 2 data for ABCL635, set to release Monday. The surge adds ~$205M to market cap.
Markets
yesterday
↑